Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Howard-Jones

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Hospital|May 30, 2018
Milk, Fresh from the CowJ Howard-Jones
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) InhibitorsZhili Xin, Martin K Himmelbauer, J Howard Jones, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Michael L Jones, David E Gunn, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2002
Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesisRoger A Smith, Donald L Hertzog, Martin H Osterhout, et al.
Journal of Medicinal Chemistry|November 12, 2019
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 InhibitorsMartin K Himmelbauer, Zhili Xin, J Howard Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonistsGaetan H Ladouceur, James H Cook, Donald L Hertzog, et al.
Journal of Medicinal Chemistry|October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Journal of Medicinal Chemistry|May 4, 2021
Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In VivoTamara Halkina, Jaclyn L Henderson, Edward Y Lin, et al.
Journal of Medicinal Chemistry|May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple SclerosisMartin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Hospital|May 30, 2018
Milk, Fresh from the CowJ Howard-Jones
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) InhibitorsZhili Xin, Martin K Himmelbauer, J Howard Jones, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Michael L Jones, David E Gunn, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2002
Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesisRoger A Smith, Donald L Hertzog, Martin H Osterhout, et al.
Journal of Medicinal Chemistry|November 12, 2019
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 InhibitorsMartin K Himmelbauer, Zhili Xin, J Howard Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonistsGaetan H Ladouceur, James H Cook, Donald L Hertzog, et al.
Journal of Medicinal Chemistry|October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Journal of Medicinal Chemistry|May 4, 2021
Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In VivoTamara Halkina, Jaclyn L Henderson, Edward Y Lin, et al.
Journal of Medicinal Chemistry|May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple SclerosisMartin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Pageof 1